Czech National Bank Grows Holdings in HCA Healthcare, Inc. $HCA

Czech National Bank grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 3.7% in the second quarter, HoldingsChannel.com reports. The firm owned 44,201 shares of the company’s stock after acquiring an additional 1,569 shares during the period. Czech National Bank’s holdings in HCA Healthcare were worth $17,234,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of HCA. Sumitomo Life Insurance Co. increased its holdings in HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after acquiring an additional 20 shares during the last quarter. MJP Associates Inc. ADV grew its position in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after purchasing an additional 21 shares in the last quarter. Cary Street Partners Investment Advisory LLC boosted its stake in HCA Healthcare by 7.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock valued at $140,000 after buying an additional 21 shares during the last quarter. Anchyra Partners LLC increased its stake in HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after acquiring an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd boosted its position in shares of HCA Healthcare by 0.6% during the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after acquiring an additional 22 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $412.80 on Friday. The business’s 50 day moving average price is $389.00 and its 200-day moving average price is $448.75. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The company has a market cap of $89.37 billion, a price-to-earnings ratio of 13.82, a PEG ratio of 1.42 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm posted $6.84 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.45%.

Analyst Ratings Changes

HCA has been the topic of a number of recent research reports. Morgan Stanley decreased their price target on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. Royal Bank Of Canada restated an “outperform” rating and set a $435.00 target price on shares of HCA Healthcare in a research report on Monday, July 27th. Argus dropped their price target on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. JPMorgan Chase & Co. lowered their price objective on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. Finally, Leerink Partners cut their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating on the stock in a research report on Monday, April 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $465.59.

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.